NeoTYPE™ Cancer Profiles
NeoTYPE™ Cancer Profiles are multi-method test panels, that identify the genetic changes most significant to therapy decisions, prognosis, diagnostic confirmation, and clinical research. Each Profile is based on comprehensive mutation detection by Sanger sequencing or next-gen sequencing, with additional analysis by FISH or flow cytometry as indicated.
These Profiles provide pathologists and oncologists with a practical approach to understanding the cancer’s biology so they can most effectively manage their patients’ care. Tests are appropriate for newly diagnosed or relapsing patients, or those with an unusual clinical presentation. With a single sample submission and integrated report, our clients receive the most current and appropriate genetic assessments available for their patients’ tumors.
We offer a wide selection of Solid Tumor Profiles and Hematology Profiles, most with ordering options enable either a tightly-focused or a broader genetic assessments of the tumor. Full test details can be reviewed here: NeoTYPE Cancer Profiles.
Thank you for your interest, and please contact us with any questions or comments.